PRELUDE CAPITAL MANAGEMENT, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$216,204
-14.6%
8,462
-4.1%
0.01%
-12.5%
Q2 2023$253,130
-16.1%
8,826
-29.9%
0.02%
-11.1%
Q1 2023$301,878
+63.2%
12,594
+7.2%
0.02%
+260.0%
Q2 2022$185,000
-67.0%
11,753
-8.9%
0.01%
-64.3%
Q4 2020$560,000
-76.6%
12,900
-76.9%
0.01%
-87.9%
Q3 2020$2,391,000
+555.1%
55,727
+614.4%
0.12%
+480.0%
Q2 2020$365,000
-14.3%
7,800
-75.1%
0.02%
-31.0%
Q1 2020$426,000
+27.2%
31,339
+1.5%
0.03%
+123.1%
Q4 2019$335,000
+44.4%
30,861
+36.4%
0.01%
+30.0%
Q3 2019$232,000
+40.6%
22,630
+29.2%
0.01%
+25.0%
Q2 2019$165,00017,5170.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 8,394$264,6630.19%
Global Wealth Strategies & Associates 100$3,1530.00%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders